[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Indivior Pharmaceuticals Inc (INDV)

Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Indivior Pharmaceuticals Inc 10710 Midlothian Turnpike Suite 125 North Chesterfield VA 23235 USA

www.indivior.com Employees: 838 P: 804-379-1090

Sector:

Medical

Description:

Indivior Pharmaceuticals Inc., together with its subsidiaries, develops, manufactures and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders principally in the United States, Europe, Canada, Australia and internationally. Indivior Pharmaceuticals Inc., formerly known as Indivior PLC., is based in Chesterfield, Virginia.

Key Statistics

Overview:

Market Capitalization, $K 4,563,601
Enterprise Value, $K 4,687,601
Shares Outstanding, K 118,014
Float, K 117,141
% Float 99.26%
Short Interest, K 11,277
Short Float 9.56%
Days to Cover 7.58
Short Volume Ratio 0.82
% of Insider Shareholders 0.74%
% of Institutional Shareholders 60.33%

Financials:

Annual Sales, $ 1,239 M
Annual Net Income, $ 210,000 K
Last Quarter Sales, $ 317,000 K
Last Quarter Net Income, $ 89,000 K
EBIT, $ 332,000 K
EBITDA, $ 352,000 K

Growth:

1-Year Return 76.05%
3-Year Return 65.69%
5-Year Return 245.27%
5-Year Revenue Growth 91.50%
5-Year Earnings Growth 525.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.15 on 08/03/26
Next Earnings Date 10/29/26
Earnings Per Share ttm 3.01
EPS Growth vs. Prev Qtr 19.79%
EPS Growth vs. Prev Year 125.49%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 10/11/22

INDV Ratios

Ratio
Price/Earnings ttm 10.61
Price/Earnings forward 10.58
Price/Earnings to Growth N/A
Return-on-Equity % -283.11%
Return-on-Assets % 36.85%
Profit Margin % 16.95%
Debt/Equity -3.38
Price/Sales 3.69
Price/Cash Flow 14.24
Price/Book N/A
Book Value/Share -1.18
Interest Coverage 6.31
60-Month Beta 0.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.